Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Thrombocytosis D013922 4 associated lipids
Toxemia D014115 3 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Klebsiella Infections D007710 7 associated lipids
Ascites D001201 25 associated lipids
Albuminuria D000419 18 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Parkinson Disease D010300 53 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Bronchial Diseases D001982 3 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Tangier Disease D013631 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Van de Weerdt ML et al. Ketoprofen and phenylbutazone attenuation of PAF-induced lung inflammation in calves. 1999 Vet. J. pmid:10030127
Yaffe MB et al. Priming of the neutrophil respiratory burst is species-dependent and involves MAP kinase activation. 1999 Surgery pmid:10455891
Zardini DM et al. Release of O2- by human umbilical cord blood-derived eosinophils: role of intra- and extracellular calcium. 1999 Cell Calcium pmid:10463102
Qu XW et al. Type I nitric oxide synthase (NOS) is the predominant NOS in rat small intestine. Regulation by platelet-activating factor. 1999 Biochim. Biophys. Acta pmid:10446403
Alvi SA et al. The production of interleukin-1beta from human fetal membranes is not obligatory for increased prostaglandin output. 1999 Immunology pmid:10447739
Wang H et al. Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora. 1999 Immunology pmid:10447766
Birk-Sørensen L et al. Platelet activating factor antagonism in pure skin flaps exposed to ischaemia-reperfusion injury. 1999 Scand J Plast Reconstr Surg Hand Surg pmid:10450571
Shen ZQ et al. Effect of protopine on cytosolic Ca2+ in rabbit platelets. 1999 Zhongguo Yao Li Xue Bao pmid:10452120
Bandeira-Melo C et al. Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats. 1999 Br. J. Pharmacol. pmid:10385228
Tremblay G BN 52021 decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis. 1999 Mediators Inflamm. pmid:10704058
Fujii E et al. Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice. 1999 Microvasc. Res. pmid:10388605
Bocheński J et al. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats. 1999 J. Physiol. Pharmacol. pmid:10424723
Lo EJ et al. Bradykinin-induced neurogenic migration of neutrophils into the rat knee joint. 1999 Neuroreport pmid:10716216
Asano K et al. Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. 1999 Biochem. Biophys. Res. Commun. pmid:10425216
Chen C and Bazan NG Platelet-activating factor inhibits ionotropic GABA receptor activity in cultured hippocampal neurons. 1999 Neuroreport pmid:10716218
Fu Y and Hu YM Prophylactic effects of tetramethyl pyrazine on mice with endotoxemia and its relationship with platelet-activating factor. 1999 Zhongguo Yao Li Xue Bao pmid:10678147
McCall MR et al. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. 1999 Biochim. Biophys. Acta pmid:9931415
Cepinskas G et al. PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. 1999 J. Cell. Sci. pmid:10341212
Ohshige A et al. Increased platelet-activating factor-acetylhydrolase activity in the umbilical venous plasma of growth-restricted fetuses. 1999 Obstet Gynecol pmid:9932551
Calcerrada MC et al. Platelet-activating factor stimulation of p125(FAK) and p130(Cas) tyrosine phosphorylation in brain. 1999 Brain Res. pmid:10415383
Lee LW et al. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation. 1999 Eur. J. Pharmacol. pmid:9932729
M'Rabet L et al. Differential fMet-Leu-Phe- and platelet-activating factor-induced signaling toward Ral activation in primary human neutrophils. 1999 J. Biol. Chem. pmid:10419502
Geijsen N et al. Regulation of p21rac activation in human neutrophils. 1999 Blood pmid:10419906
Shan L et al. Platelet-activating factor increases the expression of metalloproteinase-9 in human bronchial epithelial cells. 1999 Eur. J. Pharmacol. pmid:10422651
Harris NR et al. Influence of arteriovenular pairing on PAF-induced capillary filtration. 1999 Am. J. Physiol. pmid:9887023
Wang X et al. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis. 1999 Int. J. Pancreatol. pmid:10211421
Longphre M et al. Ozone-induced pulmonary inflammation and epithelial proliferation are partially mediated by PAF. 1999 J. Appl. Physiol. pmid:9887149
Nagahata Y et al. Role of platelet activating factor on severity of ischemic colitis. 1999 Dis. Colon Rectum pmid:10211499
Olszanecki R and Chłopicki S Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia. 1999 J. Physiol. Pharmacol. pmid:10574473
Van de Weerdt ML et al. Role of the cholinergic pathway in mediating platelet-activating factor-induced pulmonary dysfunctions in unsedated calves. 1999 Zentralbl Veterinarmed A pmid:10216447
Nagai H et al. Effect of overproduction of interleukin 5 on dinitrofluorobenzene-induced allergic cutaneous response in mice. 1999 J. Pharmacol. Exp. Ther. pmid:9862751
Kuśnierz B and Naskalski JW [Mediators of the inflammatory response in the course of acute pancreatitis]. 1999 Prz. Lek. pmid:10575924
Grassi S et al. Platelet-activating factor and group I metabotropic glutamate receptors interact for full development and maintenance of long-term potentiation in the rat medial vestibular nuclei. 1999 Neuroscience pmid:10579215
Schmidt J et al. Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer. 1999 Int. J. Pancreatol. pmid:10732294
Lee IS et al. Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. 1999 Biol. Pharm. Bull. pmid:10220282
Quinn JV and Slotman GJ Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. 1999 Crit. Care Med. pmid:10579269
Forte TM et al. Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration. 1999 J. Lipid Res. pmid:10393212
Goldfarb R Investigations into the polydeterminant nature of sepsis. 1999 Crit. Care Med. pmid:10579296
Subramanian VS et al. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma. 1999 Biochim. Biophys. Acta pmid:10395969
Mizuki M et al. Inhibition of eosinophil activation in bronchoalveolar lavage fluid from atopic asthmatics by Y-24180, an antagonist to platelet-activating factor. 1999 Life Sci. pmid:10579457
Shin BA et al. Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis. 1999 J. Nat. Prod. pmid:10579872
Rodrigues CO et al. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi. 1999 Biochem. Biophys. Res. Commun. pmid:10581161
Wu R et al. Antibodies to platelet-activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome. 1999 J. Intern. Med. pmid:10583710
Wechsung E and Houvenaghel A Influence of platelet activating factor on gastrointestinal electrical activity and some haematological and clinical parameters in the conscious miniature pig. 1999 J. Vet. Pharmacol. Ther. pmid:10597537
Bosch RJ et al. Effects of parathyroid hormone-related protein on human mesangial cells in culture. 1999 Am. J. Physiol. pmid:10600786
Wang MM et al. In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability. 1999 Biochim. Biophys. Acta pmid:9989266
Deigner HP et al. Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes. 1999 Atherosclerosis pmid:10381281
Kudolo GB and DeFronzo RA Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus. 1999 Prostaglandins Other Lipid Mediat. pmid:10410380
Harrison KA et al. Negative ion electrospray and tandem mass spectrometric analysis of platelet activating factor (PAF) (1-hexadecyl-2-acetyl-glycerophosphocholine). 1999 J Mass Spectrom pmid:10226361
Bastien Y et al. Detection of functional platelet-activating factor receptors on human tonsillar B lymphocytes. 1999 J. Immunol. pmid:10228030
Amroyan E et al. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. 1999 Phytomedicine pmid:10228608
Han SJ et al. Glucocorticoids prevent NF-kappaB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. 1999 Eur. J. Immunol. pmid:10229101
Tool AT et al. Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils. 1999 Biochem. J. pmid:10229663
Hirashima Y et al. Deficient platelet-activating factor and related enzymes in hemimegalencephaly. 1999 Childs Nerv Syst pmid:10230665
Yamaguchi S et al. Effects of Y-24180, a receptor antagonist to platelet-activating factor, on allergic cutaneous eosinophilia in mice. 1999 Life Sci. pmid:10201647
Wang X et al. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction. 1999 Br J Surg pmid:10201790
Sawai H et al. Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. 1999 J. Biol. Chem. pmid:10608884
Calcerrada MC et al. Glutamate release is involved in PAF-increased cyclic GMP levels in hippocampus. 1999 Biochem. Mol. Biol. Int. pmid:10204090
Michibayashi T Interaction between platelet-aggregating response and vasoconstrictive response to platelet activating factor. 1999 J Smooth Muscle Res pmid:10647808
Brizzi MF et al. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. 1999 Circ. Res. pmid:10205146
Torras J et al. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. 1999 Kidney Int. pmid:10571788
Grutters JC et al. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics. 1999 Eur. Respir. J. pmid:10573242
Tekgül H et al. Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis. 1999 J. Child Neurol. pmid:10573462
Hendrickson HS et al. Intramolecularly quenched BODIPY-labeled phospholipid analogs in phospholipase A(2) and platelet-activating factor acetylhydrolase assays and in vivo fluorescence imaging. 1999 Anal. Biochem. pmid:10585741
Kitsiouli EI et al. Differential determination of phospholipase A(2) and PAF-acetylhydrolase in biological fluids using fluorescent substrates. 1999 J. Lipid Res. pmid:10588961
Arbabi S et al. Priming interleukin 8 production: role of platelet-activating factor and p38. 1999 Arch Surg pmid:10593333
Powell WS et al. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils. 1999 Am. J. Respir. Cell Mol. Biol. pmid:9870930
Tsai JJ and Wang TF Different densities of human eosinophils respond differently to PAF and IL-5. 1999 J Microbiol Immunol Infect pmid:11561566
Okayama N et al. Intracellular mechanisms of hydrogen peroxide-mediated neutrophil adherence to cultured human endothelial cells. 1999 Microvasc. Res. pmid:10049654
Satoh N et al. Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma. 1999 Am. J. Respir. Crit. Care Med. pmid:10051281
Tokumura A et al. Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma. 1999 Biochim. Biophys. Acta pmid:10064906
Takami M and Tsukada W Effect of DP-1904, a thromboxane synthetase inhibitor, on antigen- and spasmogen-induced bronchoconstriction in rodents. 1999 Eur. J. Pharmacol. pmid:10082207
Liu Y et al. [The role and significance of PAF in the early pulmonary injury following burns combined with endotoxemia in rats]. 1999 Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi pmid:11501075
Delong P et al. Bacterial lipopolysaccharide induction of the prostaglandin G/H synthase 2 gene causes thromboxane-dependent pulmonary hypertension in rabbits. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10030848
Mukherjee PK et al. Glutamate receptor signaling interplay modulates stress-sensitive mitogen-activated protein kinases and neuronal cell death. 1999 J. Biol. Chem. pmid:10037742
Tsuchiya R et al. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia. 1999 Am. J. Vet. Res. pmid:10048555
Merendino N et al. Human intestinal epithelial cells express receptors for platelet-activating factor. 1999 Am. J. Physiol. pmid:10516147
Greenberg SG and Clark KE Hemodynamic effects of platelet-activating factor in nonpregnant and pregnant sheep. 1999 Am. J. Physiol. pmid:10516237
Bernatchez PN et al. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. 1999 J. Biol. Chem. pmid:10521504
Sugiura T et al. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells. 1999 Biochim. Biophys. Acta pmid:10521703
Monteiro HS et al. Glomerular effects of cholera toxin in isolated perfused rat kidney: a potential role for platelet activating factor. 1999 Pharmacol. Toxicol. pmid:10522748
Comellas A et al. Effect of platelet activating factor (PAF) on pulmonary circulation in isolated rabbit lung. 1999 J. Physiol. Biochem. pmid:10494654
GamaleÄ­ IA et al. [Post-receptor formation of active forms of oxygen in nonphagocytic cells]. 1999 Tsitologiia pmid:10496012
Dekkers PE et al. Divergent roles of tumor necrosis factor and platelet-activating factor in endotoxin-induced release of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta in chimpanzees. 1999 Infect. Immun. pmid:10496934
Tsuruta R et al. Soluble vascular cell adhesion molecule (VCAM)-Fc fusion protein induces leukotriene C4 secretion in platelet-activating factor-stimulated eosinophils. 1999 J. Leukoc. Biol. pmid:9886248
Baker KE and Curtis MJ Protection against ventricular fibrillation by the PAF antagonist, BN-50739, involves an ischaemia-selective mechanism. 1999 J. Cardiovasc. Pharmacol. pmid:10470998
Shah BH et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. 1999 Biochem. Pharmacol. pmid:10484074
Kültürsay N et al. Platelet-activating factor concentrations in healthy and septic neonates. 1999 Eur. J. Pediatr. pmid:10485307
Koyama N and Ogawa Y Elevated platelet activating factor in the tracheal aspirate at birth and signs of intra-uterine inflammation in infants with neonatal pulmonary emphysema. 1999 Eur. J. Pediatr. pmid:10486094
Piccolo MT et al. Chemotactic mediator requirements in lung injury following skin burns in rats. 1999 Exp. Mol. Pathol. pmid:10486240
Blackstone MO ICAM-1 in cerulein-induced pancreatitis. 1999 Gastroenterology pmid:10490367
Min JH et al. Membrane-bound plasma platelet activating factor acetylhydrolase acts on substrate in the aqueous phase. 1999 Biochemistry pmid:10504265
Tiemann U et al. Influence of inhibitors on increase in intracellular free calcium and proliferation induced by platelet-activating factor in bovine oviductal cells. 1999 J. Reprod. Fertil. pmid:10505057
Peplow PV Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10509861
Prescott SM et al. Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury. 1999 J. Clin. Invest. pmid:10525039
Nagase T et al. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. 1999 J. Clin. Invest. pmid:10525045
Wang X et al. Platelet-activating factor induced Ca(2+) signaling in human microglia. 1999 Brain Res. pmid:10526106
Wang R et al. [High performance thin layer chromatographic (HPTLC) determination of PAF in cerebrospinal fluid of patients with subarachnoid hemorrhage(SAH)]. 1999 Se Pu pmid:12552702
Kinlough-Rathbone RL et al. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. 1999 Thromb. Res. pmid:10527409
Vittimberga FJ et al. Endotoxin fails to stimulate inositol triphosphate production in macrophages. 1999 Int. J. Surg. Investig. pmid:11341611